Compare MXCT & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | NTIC |
|---|---|---|
| Founded | 1999 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.1M | 83.1M |
| IPO Year | 2021 | 1996 |
| Metric | MXCT | NTIC |
|---|---|---|
| Price | $0.82 | $8.08 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 931.4K | 9.0K |
| Earning Date | 05-06-2026 | 04-09-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $33,026,000.00 | ★ $84,234,474.00 |
| Revenue This Year | N/A | $11.40 |
| Revenue Next Year | $18.89 | $8.70 |
| P/E Ratio | ★ N/A | $404.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $7.10 |
| 52 Week High | $2.96 | $10.03 |
| Indicator | MXCT | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 45.34 |
| Support Level | $0.75 | $7.34 |
| Resistance Level | $0.87 | $8.58 |
| Average True Range (ATR) | 0.06 | 0.33 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 65.05 | 26.00 |
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.